← FDA DRUG APPROVALS

FDA ANDA · ANDA208765

DOXYCYCLINE HYCLATE

Sponsor: DR REDDYS LABS SA

APPLICATION
ANDA208765
TYPE
ANDA
ORIGINAL APPROVAL
2017-06-14
LATEST ACTION
2023-06-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

DOXYCYCLINE HYCLATEPrescription
DOXYCYCLINE HYCLATE EQ 75MG BASE · TABLET · ORAL
DOXYCYCLINE HYCLATEPrescription
DOXYCYCLINE HYCLATE EQ 150MG BASE · TABLET · ORAL

Approval history

2023-06-30Labeling · Supplement 3 · standardAP
2023-06-30Labeling · Supplement 1 · standardAP
2023-06-30Labeling · Supplement 2 · standardAP
2017-06-14UNKNOWN · Original · standard — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →